SINGAPORE NATIONAL EYE CENTRE
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- -
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.snec.com.sg/
Clinical Trials
76
Active:1
Completed:56
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:5
Phase 2:3
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (54 trials with phase data)• Click on a phase to view related trials
Not Applicable
32 (59.3%)Phase 3
6 (11.1%)Phase 1
5 (9.3%)Phase 4
5 (9.3%)Early Phase 1
3 (5.6%)Phase 2
3 (5.6%)Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study]
Phase 3
Not yet recruiting
- Conditions
- MyopiaStrabismus
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 40
- Registration Number
- NCT06863675
- Locations
- 🇸🇬
Singapore National Eye Centre, Singapore, Singapore
Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression
Phase 2
Not yet recruiting
- Conditions
- Myopia
- Interventions
- Drug: Atropine 0.025%Device: Single vision Contact lensDevice: Multizonal contact lensDrug: Placebo
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 180
- Registration Number
- NCT06765603
Evaluation of Performance of MiYOSMART Photochromic and Clear Spectacle Lenses in Myopic Children
Not Applicable
Not yet recruiting
- Conditions
- MyopiaMyopia Progression
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 202
- Registration Number
- NCT06717035
- Locations
- 🇸🇬
Singapore National Eye Centre, Singapore, Singapore
Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women
Early Phase 1
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: Wei's Qi Ju Gan Lu FormulaDrug: Placebo
- First Posted Date
- 2022-04-08
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 150
- Registration Number
- NCT05319041
- Locations
- 🇸🇬
Singapore National Eye Centre, Singapore, Singapore
Analysis of the Pachychoroid Phenotype in an Asian Population
Completed
- Conditions
- Pachychoroid Disease
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 112
- Registration Number
- NCT04498000
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬Singapore National Eye Centre, Singapore, Singapore
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
Singapore AI Platform Cuts Clinical Audit Time by 90%, Partners with Roche for Clinical Trial Acceleration
Enigma Health's AI platform reduced clinical audit time from 528 hours to 7 hours during a pilot at Singapore National Eye Centre, analyzing over 7,000 cataract surgeries.